AIDS-Related Mycoses: Current Progress in the Field and Future Priorities

Darius Armstrong-James; Tihana Bicanic; Gordon D Brown; Jennifer C Hoving; Graeme Meintjes; Kirsten Nielsen; Working Group from the EMBO Workshop on AIDS-Related Mycoses

doi:10.1016/j.tim.2017.02.013

AIDS-Related Mycoses: Current Progress in the Field and Future Priorities

Trends Microbiol. 2017 Jun;25(6):428-430. doi: 10.1016/j.tim.2017.02.013. Epub 2017 Apr 25.

Authors

Darius Armstrong-James¹, Tihana Bicanic², Gordon D Brown³, Jennifer C Hoving⁴, Graeme Meintjes⁴, Kirsten Nielsen⁵; Working Group from the EMBO Workshop on AIDS-Related Mycoses

Affiliations

¹ Fungal Pathogens Laboratory, National Heart and Lung Institute, Imperial College, London SW7 2AY, UK. Electronic address: d.armstrong@imperial.ac.uk.
² Institute of Infection and Immunity, St George's University of London, London SW17 0RS3, UK.
³ Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, Cape Town, South Africa; MRC Centre for Medical Mycology, Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK.
⁴ Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, Cape Town, South Africa.
⁵ Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, 55455, USA.

Abstract

Opportunistic fungal infections continue to take an unacceptably heavy toll on the most disadvantaged living with HIV-AIDS, and are a major driver for HIV-related deaths. At the second EMBO Workshop on AIDS-Related Mycoses, clinicians and scientists from around the world reported current progress and key priorities for improving outcomes from HIV-related mycoses.

Keywords: AIDS; HIV; fungal infection; immunity; mortality; translational research.

MeSH terms

AIDS-Related Opportunistic Infections / diagnosis
AIDS-Related Opportunistic Infections / drug therapy
AIDS-Related Opportunistic Infections / epidemiology
AIDS-Related Opportunistic Infections / microbiology
Acquired Immunodeficiency Syndrome / complications*
Antifungal Agents / therapeutic use
Humans
Mycoses / classification
Mycoses / diagnosis
Mycoses / drug therapy
Mycoses / etiology*
Research* / education

Substances

Antifungal Agents

Abstract

MeSH terms

Substances

Grants and funding